05/01/2025 8:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form NT 20-F | |
04/15/2025 8:05 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2025 8:07 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
04/14/2025 3:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/31/2025 4:23 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-4/A | |
03/31/2025 9:24 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
03/31/2025 8:29 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 8:20 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 8:21 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
03/03/2025 5:40 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-4/A | |
02/27/2025 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for NLSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter.
|
02/25/2025 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/25/2025 7:02 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
02/14/2025 4:08 PM | Lind Global Fund II LP (Filed by) NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025 4:43 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
02/10/2025 6:57 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
02/10/2025 6:54 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025 5:45 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
01/31/2025 6:47 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025 6:51 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/30/2025 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025 9:46 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/28/2025 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025 4:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form D Notice of Exempt Offering of Securities | |
01/16/2025 8:20 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 8:22 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/14/2025 3:27 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025 7:04 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025 7:14 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
01/07/2025 3:30 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 7:52 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 7:54 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/30/2024 5:13 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-4 Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
12/23/2024 3:04 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 3:23 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K/A | |
12/19/2024 7:30 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 7:32 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/17/2024 3:30 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024 7:30 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024 7:32 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
12/10/2024 7:30 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K/A | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
12/03/2024 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024 11:15 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form EFFECT | |
11/21/2024 3:01 PM | Hafner Ronald (Filed by) NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/18/2024 7:30 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024 4:00 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 6:27 PM | Lind Global Fund II LP (Filed by) NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/08/2024 3:00 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024 3:30 PM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
11/05/2024 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 6:39 PM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject) YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
11/04/2024 5:20 PM | Grisard Felix (Filed by) NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G/A | |
11/04/2024 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 7:02 AM | NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form 425 | |
10/28/2024 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024 3:00 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
10/22/2024 3:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024 4:19 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/18/2024 3:31 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 12:24 PM | ALPHA CAPITAL ANSTALT (Filed by) NLS Pharmaceutics (Subject) NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G | |
10/15/2024 8:09 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024 7:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024 6:00 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024 3:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024 7:13 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024 3:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024 4:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024 3:01 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
08/26/2024 3:40 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 3:30 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 8:16 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form D Notice of Exempt Offering of Securities | |
07/01/2024 7:26 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 424B5 | |
07/01/2024 7:09 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 3:54 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024 11:15 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form EFFECT | |
06/25/2024 3:31 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024 8:28 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 8:13 AM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 4:25 PM | NLS Pharmaceutics (Filer) NLS Pharmaceutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |